(Most recent first, click on the title to go to the article)

• Mingo Barba S, Ademaj A, Marder D, Riesterer O, Lattuada M, Füchslin RM, Petri-Fink A, Scheidegger S. Theoretical evaluation of the impact of diverse treatment conditions by calculation of the tumor control probability (TCP) of simulated cervical cancer Hyperthermia-Radiotherapy (HT-RT) treatments in-silico. Int J Hyperthermia. 2024;41(1):2320852. doi: 10.1080/02656736.2024.2320852. Epub 2024 Mar 11. PMID: 38465653.
• Ademaj A, Puric E, Marder D, Timm O, Kern T, Hälg RA, Rogers S, Riesterer O. Radiotherapy combined with deep regional hyperthermia in elderly and frail patients with muscle-invasive bladder cancer: quality analysis of hyperthermia and impact on clinical results. Int J Hyperthermia. 2023;40(1):2275540. doi: 10.1080/02656736.2023.2275540. Epub 2023 Nov 6. PMID: 37932002.
• De Lazzari M, Ström A, Farina L, Silva NP, Curto S, Trefná HD. Ethylcellulose-stabilized fat-tissue phantom for quality assurance in clinical hyperthermia. Int J Hyperthermia. 2023;40(1):2207797. doi: 10.1080/02656736.2023.2207797. PMID: 37196995.
• Walter J, Hader M, Sengedorj A, Fietkau R, Frey B, Gaipl US. Broadband microwave spiral applicator (105-125 MHz) for in vitro examinations of hyperthermia-induced tumor cell death forms – first analyses with human breast cancer cells. Int J Hyperthermia. 2023;40(1):2265590. doi: 10.1080/02656736.2023.2265590. Epub 2023 Oct 9. PMID: 37813393.
• Carrapiço-Seabra C, De Lazzari M, Ameziane A, van Rhoon GC, Dobšícek Trefná H, Curto S. Application of the ESHO-QA guidelines for determining the performance of the LCA superficial hyperthermia heating system. Int J Hyperthermia. 2023;40(1):2272578. doi: 10.1080/02656736.2023.2272578. Epub 2023 Oct 25. PMID: 37879635
• Gehre S, Meyer F, Sengedorj A, Grottker F, Reichardt CM, Alomo J, Borgmann K, Frey B, Fietkau R, Rückert M, Gaipl US. Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells. Front Oncol. 2023 Apr 20;13:981239. doi: 10.3389/fonc.2023.981239. PMID: 37152024; PMCID: PMC10157086.
• Ademaj A, Puric E, Timm O, Kurti D, Marder D, Kern T, Hälg RA, Rogers S, Riesterer O. Real World Analysis of Quality of Life and Toxicity in Cancer Patients Treated with Hyperthermia Combined with Radio(chemo)therapy. Cancers (Basel). 2023 Feb 15;15(4):1241. doi: 10.3390/cancers15041241. PMID: 36831583; PMCID: PMC9954584.
• Paraskevi Danai Veltsista, Eva Oberacker, Adela Ademaj, Stefanie Corradini,Franziska Eckert, Anne Flörcken, David Kaul, Lars H. Lindner, Rolf Issels, Oliver J. Ott, Daniel Pink, Vlatko Potkrajcic, Peter Reichardt, Siyer Roohani, Mateusz Jacek Spalek, Oliver Riesterer, Daniel Zips & Pirus Ghadjar (2023) Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review. International Journal of Hyperthermia, 40:1, 2236337, DOI: 10.1080/02656736.2023.2236337
• Ott OJ, Gaipl US, Lamrani A, Fietkau R. The Emerging Evidence Supporting Integration of Deep Regional Hyperthermia With Chemoradiation in Bladder Cancer. Semin Radiat Oncol. 2023 Jan;33(1):82-90. doi: 10.1016/j.semradonc.2022.10.011. PMID: 36517198.
• Saha N, Millward JM, Herrmann CJJ, Rahimi F, Han H, Lacour P, Blaschke F, Niendorf T. High-Fidelity 3D Stray Magnetic Field Mapping of Smartphones to Address Safety Considerations with Active Implantable Electronic Medical Devices. Sensors (Basel). 2023 Jan 20;23(3):1209. doi: 10.3390/s23031209. PMID: 36772249; PMCID: PMC9919430.
• Adela Ademaj, Danai P. Veltsista, Pirus Ghadjar, Dietmar Marder, Eva Oberacker, Oliver J. Ott, Peter Wust, Emsad Puric, Roger A. Hälg, Susanne Rogers, Stephan Bodis, Rainer Fietkau, Hans Crezee and Oliver Riesterer. Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment. Cancers 2022, 14, 625. https://doi.org/10.3390/cancers14030625.
• Scutigliani EM, Lobo-Cerna F, Mingo Barba S, Scheidegger S, Krawczyk PM. The Effects of Heat Stress on the Transcriptome of Human Cancer Cells: A Meta-Analysis. Cancers (Basel). 2022 Dec 24;15(1):113. doi: 10.3390/cancers15010113. PMID: 36612111; PMCID: PMC9817844
• Wust P, Veltsista PD, Oberacker E, Yavvari P, Walther W, Bengtsson O, Sterner-Kock A, Weinhart M, Heyd F, Grabowski P, Stintzing S, Heinrich W, Stein U, Ghadjar P. Radiofrequency Electromagnetic Fields Cause Non-Temperature-Induced Physical and Biological Effects in Cancer Cells. Cancers (Basel). 2022 Oct 30;14(21):5349. doi: 10.3390/cancers14215349. PMID: 36358768; PMCID: PMC9655505.Copy
• Adela Ademaj, Paraskevi D. Veltsista, Dietmar Marder, Roger A. Hälg, Emsad Puric, Thomas B. Brunner, Hans Crezee, Dorota Gabrys, Martine Franckena, Cihan Gani, Michael R. Horsman, Robert Krempien, Lars H. Lindner, Sergio Maluta, Markus Notter, Griseldis Petzold, Sultan Abdel-Rahman, Antonella Richetti, Andreas R. Thomsen, Pelagia Tsoutsou, Rainer Fietkau, Oliver J. Ott, Pirus Ghadjar & Oliver Riesterer MD  A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers. Strahlenther Onkol (2022). doi.org/10.1007/s00066-022-01980-9.
• H. Petra Kok, Timoteo D. Herrera and Johannes Crezee. The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose. Int J Radiation Oncol Biol Phys, Vol. 115, No. 4, pp. 994−1003, 2023
• Kok HP, van Rhoon GC, Herrera TD, Overgaard J, Crezee J. Biological modeling in thermoradiotherapy: present status and ongoing developments toward routine clinical use. Int J Hyperthermia. 2022;39(1):1126-1140. doi: 10.1080/02656736.2022.2113826.
• Riesterer O, Ademaj A, Puric E, Eberle B, Beck M, Gomez S, Marder D, Oberacker E, Rogers S, Hälg RA, Kern T, Schwenne S, Stein J, Stutz E, Timm O, Zschaeck S, Weyland MS, Veltsista PD, Wyler S, Wust P, Scheidegger S, Bodis S, Ghadjar P. Tetramodal therapy with transurethral resection followed by chemoradiation in combination with hyperthermia for muscle-invasive bladder cancer: early results of a multicenter phase IIB study. Int J Hyperthermia. 2022;39(1):1078-1087. doi: 10.1080/02656736.2022.2109763
• Sengedorj, A.; Hader, M.; Heger, L.; Frey, B.; Dudziak, D.; Fietkau, R.; Ott, O.J.; Scheidegger, S.; Barba, S.M.; Gaipl, U.S.; Rückert, M. The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells. Cancers 2022, 14, 2050. doi:10.3390/cancers14092050
• Carrapiço-Seabra C, Curto S, Franckena M, Rhoon GCV. Avoiding Pitfalls in Thermal Dose Effect Relationship Studies: A Review and Guide Forward. Cancers (Basel). 2022 Sep 30;14(19):4795. doi: 10.3390/cancers14194795. PMID: 36230717; PMCID: PMC9562191.
• Sengedorj, A., Hader, M., Frey, B.  Rainer Fietkau, Oliver J. Ott, Udo S. Gaipl & Michael Rückert. Interaction of Radiotherapy and Hyperthermia with the Immune System: a Brief Current Overview. Curr Stem Cell Rep 8, 129–138 (2022). doi:10.1007/s40778-022-00215-y
• Stutz E, Puric E, Ademaj A, Künzi A, Krcek R, Timm O, Marder D, Notter M, Rogers S, Bodis S, Riesterer O. Present Practice of Radiative Deep Hyperthermia in Combination with Radiotherapy in Switzerland. Cancers (Basel). 2022 Feb 24;14(5):1175. doi: 10.3390/cancers14051175. PMID: 35267486; PMCID: PMC8909523.
• Scheidegger, S.; Mingo Barba, S.; Gaipl, U.S. Theoretical Evaluation of the Impact of Hyperthermia in Combination with Radiation Therapy in an Artificial Immune—Tumor-Ecosystem. Cancers. 2021, 13, 5764. https://doi.org/10.3390/cancers13225764